Health Care & Life Sciences » Pharmaceuticals | Proteomics International Laboratories Ltd.

Proteomics International Laboratories Ltd.

Proteomics International Laboratories Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.02
Market Cap
AUD26.63 M
Shares Outstanding
80.1 M
Public Float
-

Profile

Address
QEII Medical Centre
Perth Western Australia (WA) 6009
Australia
Employees -
Website http://www.proteomics.com.au
Updated 07/08/2019
Proteomics International Laboratories Ltd. is a biological research and drug discovery company. It operates through three synergistic business units: Analytical services, Diagnostics and Therapeutics. The Analytical services unit engages in contract research, analytical testing and consultancy.

Financials

View All

Richard Lipscombe
Managing Director & Director
Paul House
Non-Executive Director